Inspire Newsroom

Inspire’s latest study, presented at ICPE 2023, sheds light on the diagnostic journeys, treatment patterns, and healthcare utilization of short bowel syndrome (SBS) patients. By linking patient data with HIPAA-compliant medical and pharmacy claims, the study reveals prolonged reliance on parenteral nutrition and significant out-of-pocket costs. Insights from Inspire’s online community further emphasize the financial and quality-of-life impacts of SBS, providing valuable context for understanding patient needs and advancing care solutions.

Inspire and the Vasculitis Foundation have joined forces to launch a dedicated online community for individuals affected by vasculitis and their care partners. This partnership aims to provide support, resources, and a space for shared experiences while raising awareness of this rare autoimmune disease.

Inspire unveiled findings from a groundbreaking study on chronic inflammatory demyelinating polyneuropathy (CIDP) at ISPOR 2023. Using Inspire RWE Solutions to link patient-generated data with claims, the study revealed diagnostic delays, significant healthcare utilization, and key patient insights, highlighting the importance of real-world evidence in understanding rare diseases.

Inspire has introduced its Real-World Evidence (RWE) solutions, combining patient engagement data with advanced analytics to support biopharma and life sciences companies. By leveraging longitudinal patient insights across thousands of conditions, Inspire RWE aims to drive better patient outcomes and advance patient-centered healthcare.

Demand for cosmetic procedures has risen sharply in the U.S. However, there is a lack of data around specific experiences and unmet needs among diverse populations including Black and transgender individuals.

Inspire is pleased to announce that it has partnered with the Autoimmune Association to launch a new community for patients living with autoimmune diseases and their caregivers.